mechanism. [4] [5] [6] [7] [8] In spite of the controversy engendered by extensive hypotheses, [9] [10] [11] [12] there is a growing consensus that anomalies of bone growth and development are strongly related to the onset and progression of scoliosis. [13] [14] [15] [16] [17] Mesenchymal stem cells (MSCs) act as progenitors of osteoblasts and regulate osteoclastogenesis via Receptor Activator for Nuclear Factor-k B Ligand and osteoprotegerin expression. [18] [19] [20] In addition, MSCs are indispensable in both intramembranous and endochondral bone formation. 20 Given the functional characteristics of MSCs in bone formation and resorption, we hypothesized that MSCs play a significant role in the etiology and pathogenesis of AIS.
Our previous study 21 identified 25 differentially expressed proteins in MSCs from AIS patients using twodimensional differential gel electrophoresis (2D-DIGE) and MS-based proteomic approaches, and the function analysis of these proteins suggested increased proliferation ability of MSCs and decreased osteogenic differentiation ability in AIS. These results were further supported by Park et al's study, 22 which revealed lower osteogenic differentiation abilities and alkaline phosphatase (ALP) activities of MSCs from AIS patients, indicating that the decreased osteogenic differentiation ability of MSCs might be a possible mechanism leading to low bone mass in AIS. In addition, a recent study disclosed that the adipogenic ability of MSCs from AIS girls was lower than controls. 23 Based on these findings, we used a microarray approach in this study to further investigate specific alterations in the genetic expression profile of MSCs from AIS patients. Furthermore, the gene expression data were processed by gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) orthology, and Signal network, which are effective bioinformatics analytical methods.
MATERIALS AND METHODS

Patients and Specimens
Bone marrow (BM) aspirates were obtained from 10 AIS patients (mean age 14.3 yr, range [12] [13] [14] [15] [16] [17] and five non-AIS patients with lower-leg fracture (mean age 14.6 yr, range 12-17) ( Table 1 ). In the AIS group, all of the patients underwent full clinical and radiological examinations to rule out other causes of scoliosis and to ascertain the diagnosis of AIS. 24, 25 In the control group, each of the five age-and sexmatched subjects had a straight spine and a normal forward bending test on the physical examination. They were confirmed to be free of any associated medical diseases or spinal deformities when entered to the study. The study was approved by the Ethics Committee of Peking Union Medical College Hospital. Written informed consents were obtained from all subjects and their parents before entering the study.
Isolation and Culture, Immunophenotype Analysis, Osteogenic and Adipogenic Differentiation of BM-MSCs
As described in our previous study, 21 BM-MSCs were isolated using the same techniques and confluent cells (approximately 2 Â 10 6 ) at the third passage were used for the following experiments. Primary antibodies against human CD29, CD31, CD34, CD44, CD45, CD73, and CD105 (BD Biosciences) were used for immunophenotype analysis of BM-MSCs. To identify the MSC capacity for multilineage differentiation, MSCs were cultured under differentiation conditions. As previously described, 21 cells were stained with the ALP staining kit (Beyotime, China) to reveal osteogenic differentiation and stained with fresh Oil Red O solution (Sigma, St.Louis, MO, USA) to show lipid droplets in induced cells.
Total RNA Extraction and Microarray Assay
RNA was extracted from MSCs using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). Following purification with an RNeasy kit (Qiagen, Valencia, CA), cDNA was generated using One-Cycle Target Labeling and Control Reagents (Affymetrix, Santa Clara, CA), and cRNA was created with a GeneChip IVT Labeling Kit (Affymetrix, Santa Clara, CA). Biotin-labeled, fragmented ( 200 nt) cRNA was then hybridized for 16 hours at 458C to Affymetrix GeneChip HumanTranscript 2.0 arrays (Affymetrix). GeneChips were washed and stained in the Affymetrix Fluidics Station 450. GeneChips were scanned by using Affymetrix GeneChip Command Console (AGCC) which installed in GeneChip Scanner 3000 7G. The data were analyzed with robust multichip analysis algorithm using Affymetrix default analysis settings and global scaling as normalization method. Values presented are log2 robust multichip analysis signal intensity.
Differentially expressed genes (DEGs) were identified based on random-variance model t test and false discovery rate (FDR) analysis. P < 0.05 and FDR < 0.05 was set as a threshold. Cluster 3.0 and TreeView analysis (Stanford University, California, USA) were performed to generate a dendrogram for each cluster of genes based on their expression profiling similarities.
GO and Pathway Analysis
Functional analysis of DEGs was carried out by the GO project (http://www.geneontology.org) on the basis of biological process [31] , while pathway analysis was used to find out the significant pathway of the differential genes according to KEGG (http://www.genome.jp/kegg/). The Fisher exact test and x 2 test were used to classify the GO category and pathway, and the FDR was calculated to correct the P value. P < 0.05 and FDR < 0.1 were used as a threshold to select significant GO categories and pathways.
Signal Transduction Networks Analysis
Gene signal transduction network analysis (Signal-net), based on KEGG database about the interactions between different gene products and the theory of network biology) was constructed based on the data of DEGs in significant pathways. The ''degree'' is defined as the number of interactions of a gene with other genes in the gene network. Genes with higher degrees occupied more central positions in the network and had a stronger capacity of modulating adjacent genes.
Validation of Microarray Data by Real-Time PCR
Twenty-four genes (MAP2K1, SMAD3, HOXC6, HSPA6, GTF2I, CREBBP, PIK3R2, DUSP2, etc) were selected for validation based both on their positions in signal network and their potential biological functions. Total RNA was isolated from the third passage of BM-MSCs from 10 AIS patients and five controls. RNA was reverse transcribed using ReverTra Ace qPCR RT Kit (TOYOBO, Osaka, Japan). Quantitative Real-time reverse transcription polymerase chain reaction (qRT-PCR) was conducted in 20-mL reactions consisting of 10-mL SYBR Green Real-time PCR Master Mix, 1-mL 10-mM forward primers, 1-mL 10-mM reverse primers (listed in Table 2 ), 1-mL template cDNA, and 7-mL double-distilled water. The PCR cycling programs began with an initial denaturation for 5 minutes at 948C, followed by 40 cycles of 30 seconds at 948C, 30 seconds at 608C-658C, 30 seconds at 728C, and ended with the step of melting curve. The relative changes in gene expression were calculated by 2 À44CT method; glyceraldehyde-3-phosphate dehydrogenase was used as an internal control gene to normalize the amount of RNA added to the PCR reactions. 50 
RESULTS
The Biological Characteristics of MSCs
All of the cultured cells from AIS patients and controls grew well and displayed fibroblast-like morphology when observed under a light microscope. To verify that these isolated cells were MSCs, we investigated their immunophenotypes and multilineage differentiation capacities. These cells from both the AIS and control groups were persistently negative for CD31, CD34, and CD45, but expressed high levels of CD29, CD44, CD73, and CD105 (Supplementary 
Microarray Gene Expression
An unsupervised hierarchical clustering of the microarray data ( Figure 1 ) revealed significant gene expression changes (random-variance model t test P < 0.05 and FDR P < 0.05) in 1027 genes in AIS MSCs, as compared to controls (Supplementary Table 1 , http://links.lww.com/BRS/B80). Among these 1027 genes, 551 were upregulated (such as SMAD3, HOXC6, HOXC9, GTF2I, CREBBP, PIK3R2, DUSP2, platelet-derived growth factor receptor, alpha polypeptide PDGFRA) and 476 were downregulated (such as MAP2K1, heat shock 70kDa protein 5, phosphoglycerate kinase 1, HSPA6, and ribophorin I).
GO Analysis and Pathway Analysis Based on DEGs
In our study, the main GO categories for upregulated genes were related to functions such as small GTPase-mediated signal transduction, DNA-dependent transcription, cytokinesis, completion of separation, etc ( Figure 2A ). The main GO categories for downregulated genes were related to functions such as small molecule metabolic process, cell adhesion, transmembrane transport, immune response, etc ( Figure 2B ). The differential genes within the significant GO categories are shown in Supplementary and Notch signaling pathway were upregulated ( Figure 3A ), while MAPK signaling pathway, phosphatidylinositol-3 kinase (PI3K)-Akt signaling pathway, PPAR signaling pathway were downregulated ( Figure 3B ). The DEGs within significant pathways are shown in Supplementary Table 3 , http://links.lww.com/BRS/B80.
Signal Network Analysis of DEGs From Significant Pathways
Gene signal transduction network was constructed based on the data of DEGs contained in significant pathways ( Figure 4 ) (Supplementary Table 4 , http://links.lww.com/ BRS/B80). From the most significant central genes, a total of 24 genes (MAP2K1, SMAD3, HOXC6, HSPA6, GTF2I, CREBBP, PIK3R2, DUSP2, etc) were selected for further real-time PCR validation considering both their positions in the network and their potential biological functions. These genes might be of great importance to construction of the gene-gene interaction network in AIS MSCs, and therefore to AIS pathogenesis and accompanied osteopenia. The genegene interaction network of these 24 genes was also presented ( Figure 5 )
Differential Genes Matched With Previously Recognized Dysregulated Proteins of AIS MSCs
In our previous study, 25 differentially expressed proteins of MSCs from AIS patients were identified using 2D-DIGE and MS-based proteomic approaches. 21 Therefore, the differential expressed genes in the present study were matched with these previously recognized dysregulated proteins. Seventeen differential genes in this study encode proteins that belong to the same family as the differential proteins in our previous research, which indicated that these genes required further concern and analysis ( Table 3) .
Profiled Genes Versus Previously Reported AIS Candidate Regions
Several chromosomal loci predisposing to AIS have been identified by genetic linkage and genome-wide association studies. [26] [27] [28] [29] [30] [31] [32] [33] But to date, no genes have been clearly identified as causative in AIS. We therefore attempted to identify if there were any significantly differentially regulated genes in AIS MSCs within the reported loci. A total of 84 genes were identified as corresponding with previously reported AIS candidate loci (Table 4) .
Validation of Microarray Data by qRT-PCR Analysis
To independently confirm the microarray results, 24 genes were chosen for real-time quantitative PCR validation in 10 AIS patients and five controls. The changes in the expression levels of the validated genes were paralleled in microarray and qRT-PCR experiments, thereby confirming our results ( Figure 6A,B) . NM_001975  CGTTATTGGCATGGATGTTG  CCCAGTGATGTATCGGGAAG  PGK1  NM_000291  ATGGATGAGGTGGTGAAAGC  CAGTGCTCACATGGCTGACT  MAP2K1  NM_002755  TGGATGGAGGTTCTCTGGAT  TAGGATGTTGGAGGGCTTGA  HSPA5  NM_005347  TAGCGTATGGTGCTGCTGTC  TGACACCTCCCACAGTTTCA  SERPINE1  NM_000602  GCTGTGTGTGAGCAGTGGAC  CATCTTTGTGCCCTACCCTCT  TPM3  NM_001043351  AGTCCCTCCAACCCTCAGAC  GCTACCACCCACAAAGATGC  RPN1  NM_002950  CTGGATTATGGGCCTTTCAG  GTCATGCTGGTGATGGTCAG  HSPA6  NM_002155  AGCAGACCCAGACTTTCACC  AGCAGGTTGTTGTCCTTGG  ERBB2  ENST00000540147  TGCTGTCCTGTTCACCACTC  TGCTTTGCCACCATTCATTA  SMARCC2  NM_001130420  GGCAAGGATGAGGATGAGAA  TGATGATGTGGTGGGTCTGT  PIK3R2  NM_005027  GATGGGCACTATGGCTTCTC  TCCAGCTTGGCATTGTACTG  SIK2  NM_015191  AGGTCAATGGCTGTCTGCTT  GCCTCTCCTTCTGTCTCCAG  HOXC9  NM_006897  GCTGGAACTGGAGAAGGAGTT  GGCTGGGTAGGGTTTAGGAC  CREBBP  NM_001079846  CACAAACCCACTGATGAACG  GTGCCAGCCTTTCCTTACAC  CDK19  NM_015076  CGGCTTGTAGAGAGATTGCAC  CAGCAGCCATACCTTCCTGT  GTF2I  NM_001163636  GGATGGTGGTGACATTCCTC  TCAGTTCCGACGACAAACAC  SMAD3  NM_001145102  CTGAAGCGCACTGACCATAA  ATGCAGTTGTCCCATCCTGT  HBP1  NM_012257  TTTGCCATCTTCACCTGGAT  CATGCCAGATTGGGTAGGAT  KAT2B  NM_003884  GCCGTGTTATTGGTGGTATCT  CCATAGCCCTTGACTTGCTC  PDGFRA  NM_006206  CGGTCTTGGAAGTGAGCAGT  TGTAAATGTGCCTGCCTTCA  DDB2  NM_000107  TTCTGGCATCAGTTCGCTTA  ACTTCCGTGTCCTGGCTTC  DUSP2  NM_004418  AACCAAGGGTGTGTCTGCTC  CCAAGGGCTTCAACATGG  DUSP6  NM_001946  ACAACAGGGTTCCAGCACA  CAGACACATTCCAGCAAGGA  HOXC6  NM_004503  CGCACAACTCTCTTTCACCA 
DISCUSSION
In the present study, to investigate the molecular mechanism of decreased osteogenic differentiation ability of MSCs and gain an insight into the pathogenesis of AIS, we employed microarray approach and integrated gene network analysis to explore the differential genetic expression profile, GO terms, and KEGG pathways in MSCs of AIS and non-AIS controls. To the best of our knowledge, this study is the first microarray research on AIS in the field of MSCs.
Our results suggest that 1027 previously unrecognized genes were differentially expressed in MSCs from AIS patients. These genes are involved in multiple biological processes, including small GTPase-mediated signal transduction, DNA-dependent transcription, cytokinesis, cell adhesion, transmembrane transport, immune response, etc. Results from pathway analysis revealed dysregulated MAPK signaling pathway, PI3K-Akt signaling pathway, calcium signaling pathway, PPAR signaling pathway, ubiquitin-mediated proteolysis, and Notch signaling pathway, all of which have been reported to play important role in the MSC osteogenic or adipogenic differentiation. [34] [35] [36] Together, the analysis of GO and pathway enrichment of these DEGs have provided novel insight into the molecular pathogenesis of AIS initiation and development.
Our signal network analysis of DEGs involved in significant pathways could construct the gene-gene interaction network from differential genes, and could find the central genes with the highest degree. In this study, 24 potential crucial genes, including MAP2K1, SMAD3, HOXC6, HSPA6, GTF2I, CREBBP, PIK3R2, DUSP2, were selected for validation considering both their positions in the network and potential biological functions, which may play essential roles in AIS pathogenesis and accompanied osteopenia.
MAP2K1 gene was demonstrated by our study downregulated in AIS MSCs, which encode a mitogen-activated protein kinase. Many previous studies have shown that MAP2K1 lies upstream of extracellular signal-regulated kinases (ERKs) and plays an important role in osteogenic differentiation of MSCs and bone formation in vivo.
37,38 A constitutively active MAP2K1 can induce osteoblast gene expression, while inhibition of MAPK signaling intermediates blocked differentiation. 39 In addition, MAPK activation via transfection of cells with constitutively active MAP2K1 (MAP2K1-SP) could induce the RuntRelatedTranscriptionFactor2 (RUNX2)-responsive osteocalcin (OCN) gene while dominant-negative MAP2K1 was inhibitory. 40 Furthermore, transgenic study revealed that dominant-negative MAP2K1 mice showed decreased skeletal size and calvarial mineralization while these parameters were increased in MAP2K1-SP mice. 38 Taken together these data suggest that downregulated expression of MAP2K1 might play a significant role in the osteopenia in AIS and the development of the disease.
Another important upregulated gene in AIS MSCs encodes SMAD3, a transcriptional modulator activated by transforming growth factor-b (TGF-b). It has been showed that SMAD3 activated by TGF-b inhibits the expression of Runx2 and other Runx2 target genes, resulting in inhibition of osteoblast differentiation of MSCs. 41, 42 In vivo, osteoblasts and chondrocytes from SMAD3À/À mice are unable to slow the progression of terminal differentiation, which results in premature chondrocyte hypertrophy and growth plate mineralization and consequent chondrodysplasia. 43 These previous findings and our observation suggest that increased SMAD3 expression might be responsible, at least in part, for the reduction of osteogenic differentiation ability of AIS MSCs and persistent general osteopenia of AIS patients.
HOXC6 and homeobox C9 (HOXC9), which are members of the Homeobox (HOX) gene family, were both upregulated in AIS MSCs according to our results. Many previous experiments have shown that HOX genes play a critical role in global patterning of the vertebrate axial skeleton 44, 45 direct functional evidence for this role has been provided by both gain-and loss-of-function experiments. [46] [47] [48] Interestingly, a recent microarray analysis of AIS compared with non-AIS osteoblasts identified differential expression of HOXA group genes (10, 11, and 13), of HOXB group genes (2-8) and of HOXD (1-4) , as the most up-and downregulated genes. 49 These findings and our results strongly suggested that HOX gene family may be of significance in the etiology of AIS and thus worth of in-depth exploration. HSPA6, which was downregulated in MSCs from AIS group in this study, encodes heat shock protein 70 (HSP70). It should be noted that HSP70, being consistent with this study, has also been demonstrated to be downregulated expressed in AIS MSCs in our previous comparative proteomics research. 21 Many studies have reported that HSP70 was involved in proliferation, differentiation, and apoptosis of BMSCs, by correcting misfolded proteins or helping fold newly synthesized proteins during physiological processes. [50] [51] [52] Furthermore, HSP70 has been reported to activate ERK1/2 pathways for controlling proliferation and osteogenic differentiation of MSCs. 53, 54 Since our serial studies have shown the downregulation of HSP70 at both genetic and protein levels, it is highly likely that its lower expression might subsequently compromise the capacity of MSCs to cope with aberrant polypeptides or damaged proteins caused by environmental pathogenic factors of AIS. In addition, HSP70, as a mediator of osteogenic differentiation, might be related to decreased differential ability of MSCs and clinical osteopenia in AIS patients.
Other notable dysregulated genes include GTF2I, CREBBP, PIK3R2, and DUSP2. GTF2I encodes vertebratespecific transcription factors TFII-I, which was reported to play an inhibitory role in regulating genes that are essential in osteogenesis. 55 CREBBP encodes a nuclear protein that binds to cAMP-response element binding protein (CREB), which is upstream of Runx2. The CREB-Smad6-Runx2 axis was reported to play an essential role in the impaired osteogenesis of BMSCs with the fibrous dysplasia phenotype. 56 PIK3R2 encoded protein is a regulatory component of PI3K, and Seventeen differential genes in this study encode proteins that belong to the same family as the differential proteins in our previous research, which indicated that these genes required further concern and analysis. AIS-MSCs indicates adolescent idiopathic scoliosis-mesenchymal stem cells; FDR, false discovery rate; mRNA, messenger ribonucleic acid. The table presents a total of 84 genes within previously reported AIS candidate loci identified by genetic linkage and genome-wide association studies. AIS indicates adolescent idiopathic scoliosis; FDR, false discovery rate. PI3K/Akt signaling pathway and downstream targets have been shown to be critical regulators of bone formation and remodeling. 35, 57 DUSP2 gene product is reported to negatively regulate members of the mitogen-activated protein kinase superfamily, which play an important role in osteogenic differentiation of MSCs and bone formation in vivo. 58 In addition, other significant dysregulated genes presented in Figure 6 , such as K(lysine) acetyltransferase 2B (KAT2B), erythroblastic leukemia viral oncogene homolog 2 (ERBB2), DUSP6, tropomyosin 3 (TPM3), enolase 2 (ENO2), and damage-specific DNA binding protein 2 (DDB2), are also worth our concern. KAT2B encodes a catalytic subunit for histones acetylation, which is an important regulator for promoting osteoblast differentiation via acetylation modification of Runx2. 59, 60 ERBB2 encodes a member of the epidermal growth factor receptor family, which can enhance kinase-mediated activation of MAPK and PI3K signaling pathways. 61, 62 DUSP6 encodes a dual specificity phosphatase exclusively specific to MAPK1/ ERK2, which is demonstrated to play a negative regulatory role in MAPK1 in a feedback loop manner. 63, 64 TPM3 gene product provides stability to actin filaments and regulates access of actin-binding proteins. Interestingly, it was revealed that disrupting actin in MSCs increased adipogenesis and decreased osteogenesis when compared to untreated controls, suggesting that the actin cytoskeleton might be important in the commitment process.
65 ENO2 encodes one of the three enolase isoenzymes (a, b, g), while a-enolase was reported to be downregulated expressed in AIS MSCs in our previous proteomics research. 21 DDB2-encoded protein participates in nucleotide excision repair, and facilitates the cellular response to DNA damage. 66, 67 The possible mechanism of the observed dysregulation of these genes expression in the etiology of AIS required further research and elucidation. In summary, we described the differential gene expression profiles of BM-MSCs from AIS patients and related potential pathways for the first time. These previously unrecognized genes and molecular pathways might play a significant role, in not only the causal mechanism of osteopenia in AIS, but also the initiation and development of AIS. The identification of these candidate genes provides novel insight into the underlying etiological mechanisms of AIS. Further studies are required to clarify the underlying mechanism of MSCs in AIS pathogenesis.
Key Points
Differential genes expression profiles of BM-MSCs from AIS patients and related potential pathways were reported for the first time. A total of 1027 previously unrecognized genes were differential expressed in MSCs from AIS patients. MAPK signaling pathway, PI3K-Akt signaling pathway, calcium signaling pathway, PPAR signaling pathway, ubiquitin-mediated proteolysis, and Notch signaling pathway were dysregulated in AIS MSCs. MAP2K, SMAD3, HOXC6, HSPA6, GTF2I, CREBBP, PIK3R2, DUSP2 may play essential roles in AIS pathogenesis and accompanied osteopenia.
